Market revenue in 2023 | USD 2.0 million |
Market revenue in 2030 | USD 2.7 million |
Growth rate | 4.7% (CAGR from 2023 to 2030) |
Largest segment | Ck |
Fastest growing segment | CRP |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Ck was the largest segment with a revenue share of 20% in 2023. Horizon Databook has segmented the Egypt blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
In Egypt, there is a growing awareness of the importance of sports, which is reflected in increasing participation and substantial funding initiatives. The government's commitment to sports development is exemplified by various programs and investments to boost sports engagement and infrastructure. For instance, in March 2022, the Sports Ministry and Banque Misr launched the Egyptian Sports Fund, a charitable investment fund designed to support the country's sports sector.
This fund, authorized by the Financial Regulatory Authority, is focused on sponsoring sports champions, funding sports-related projects at clubs and youth centers, and supporting major sporting events. This initiative represents a significant commitment to enhancing sports at all levels. As sports participation grows, the need for advanced sports medicine solutions increases.
The increased funding and sports programs reflect Egypt's commitment to adopting cutting-edge medical technologies. This demonstrates the country's dedication to advancing sports medicine and providing comprehensive care for its athletes.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account